Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05712057 · ClinicalTrials.gov registry record · NA
Neurostimulation Versus Therapy for Problems With Emotions
A NA study of Anxiety Disorders and Mood Disorders, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT05712057 is a NA study of Anxiety Disorders and Mood Disorders that is actively recruiting participants, run by Duke University. The registered enrollment target is 240 participants, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05712057, a NA study of Anxiety Disorders and Mood Disorders, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with excitatory repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlPFC). The secondary aim is to identify key changes in the emotion regulation neural network following the combined intervention versus each of the components alone. The third aim is to explore personalized biomarkers for response to emotion regulation training. Participants will undergo brain imaging while engaging in an emotional regulation task. Participants will be randomly assigned to learn one of two emotion regulation skills. Participants will be reminded of recent stressors and will undergo different types of neurostimulation, targeted using fMRI (functional MRI) results. Participants who may practice their emotion regulation skills during neurostimulation in a one-time session. Following this training, participants will undergo another fMRI and an exit interview to assess for immediate neural and behavioral changes. Measures of emotion regulation will be assessed at a one week and a one month follow up visit.
Conditions Studied
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
- BEHAVIORAL Cognitive Restructuring
- DEVICE electrical scalp stimulation
- BEHAVIORAL Emotional Awareness Training
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05712057
The ClinicalTrials.gov registry entry for NCT05712057 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (79% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 4 interventions - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.
NCT05712057 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05712057 about?
NCT05712057 is a clinical study titled "Neurostimulation Versus Therapy for Problems With Emotions". The primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with excitatory repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlPFC). The secondary a...
What is the current status of trial NCT05712057?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-05-15. Estimated completion is 2027-12-01.
What conditions does trial NCT05712057 study?
This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders, Eating Disorders, Emotion Regulation, OCD.
What interventions are being tested in trial NCT05712057?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Cognitive Restructuring (BEHAVIORAL), electrical scalp stimulation (DEVICE), Emotional Awareness Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05712057?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05712057 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.